Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers-2026/4/15

Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing-2026/4/14

Bioanalytical Method Validation for Biomarkers-2026/4/10

Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle-2026/3/30

Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle-2026/3/30

Pyrogen and Endotoxins Testing: Questions and Answers-2026/3/18

General Considerations for the Use of New Approach Methodologies in Drug Development-2026/3/18

Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs-2026/3/17

Medical Devices with Indications Associated with Weight Loss - Premarket Considerations-2026/3/13

Questions and Answers on Biosimilar Development and the BPCI Act-2026/3/9